The price of Century Therapeutics Inc (NASDAQ: IPSC) closed at $4.18 in the last session, down -2.11% from day before closing price of $4.27. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 173351 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at IPSC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.92 and its Current Ratio is at 9.92. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on August 28, 2023, Downgraded its rating to Neutral and sets its target price to $5 from $28 previously.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.
On October 31, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $15.Guggenheim initiated its Buy rating on October 31, 2022, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’24 when Farid Adrienne sold 22,831 shares for $5.14 per share. The transaction valued at 117,342 led to the insider holds 114,149 shares of the business.
Farid Adrienne sold 30,684 shares of IPSC for $152,340 on Mar 06 ’24. The Chief Operations Officer now owns 114,149 shares after completing the transaction at $4.96 per share. On Feb 16 ’24, another insider, Farid Adrienne, who serves as the Chief Operations Officer of the company, sold 485 shares for $4.86 each. As a result, the insider received 2,358 and left with 114,149 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IPSC now has a Market Capitalization of 274.18M and an Enterprise Value of 149.61M. For the stock, the TTM Price-to-Sale (P/S) ratio is 121.50 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at 66.94 whereas that against EBITDA is -1.23.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $5.51, while it has fallen to a 52-week low of $1.28. The 50-Day Moving Average of the stock is 4.3564, while the 200-Day Moving Average is calculated to be 2.9133.
Shares Statistics:
According to the various share statistics, IPSC traded on average about 220.80K shares per day over the past 3-months and 141.33k shares per day over the past 10 days. A total of 60.34M shares are outstanding, with a floating share count of 21.66M. Insiders hold about 66.58% of the company’s shares, while institutions hold 27.30% stake in the company. Shares short for IPSC as of Mar 15, 2024 were 1.64M with a Short Ratio of 7.42, compared to 1.81M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.53% and a Short% of Float of 7.18%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.5 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.56, while EPS last year was -$0.53. The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.44 and low estimates of -$0.58.
Analysts are recommending an EPS of between -$1.75 and -$2.34 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.97, with 6 analysts recommending between -$1.42 and -$2.87.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $19.77M in the next fiscal year. The high estimate is $50M and the low estimate is $400k. The average revenue growth estimate for next year is up 229.00% from the average revenue estimate for this year.
